Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0S5ZY
|
|||
| Former ID |
DNC012088
|
|||
| Drug Name |
3-Naphthalen-1-yl-1-propyl-pyrrolidine
|
|||
| Synonyms |
CHEMBL82485; 3-Naphthalen-1-yl-1-propyl-pyrrolidine
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C17H21N
|
|||
| Canonical SMILES |
CCCN1CCC(C1)C2=CC=CC3=CC=CC=C32
|
|||
| InChI |
1S/C17H21N/c1-2-11-18-12-10-15(13-18)17-9-5-7-14-6-3-4-8-16(14)17/h3-9,15H,2,10-13H2,1H3
|
|||
| InChIKey |
JPGGRFYDEHKZFB-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Regioselective synthesis of 3-aryl substituted pyrrolidines via palladium catalyzed arylation: pharmacological evaluation for central dopaminergic and serotonergic activity, Bioorg. Med. Chem. Lett. 7(3):241-246 (1997). | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.